4//SEC Filing
Landis John B. 4
Accession 0001562180-20-002045
CIK 0001314102other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:02 PM ET
Size
7.7 KB
Accession
0001562180-20-002045
Insider Transaction Report
Form 4
Landis John B.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-02-28+33,500→ 33,500 totalExercise: $1.29From: 2021-02-28Exp: 2030-02-28→ Common Stock (33,500 underlying) - Award
Restricted Stock Units
2020-02-28+19,000→ 19,000 totalExercise: $0.00From: 2021-02-28→ Common Stock (19,000 underlying)
Footnotes (1)
- [F1]Will fully vest on the one-year anniversary of the grant date.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001477283
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:02 PM ET
- Size
- 7.7 KB